Thermo Fisher Scientific is applying the power of the CRISPR-Cas9 system to high throughput screening applications with our new awarding winning pooled and arrayed CRISPR libraries. These CRISPR libraries are designed to provide you with a flexible system that adapts to your needs and your screening goals.
Arrayed CRISPR libraries designed and constructed to provide a flexible system that doesn’t impose limitations on your assay design or research goals.
High quality controls to help you optimize delivery conditions, maximize editing efficiency and establish hit selection criteria.
LentiPool CRISPR libraries are an affordable method to screen a large number of genes, as there is no high-throughput instrumentation required.
Predesigned, prepackaged CRISPR gRNA lentiviruses designed for efficient gene knockout.
Cas9 Lentivirus gives you the ability to create a stable pool of Cas9-expressing cells or to isolate stable Cas9-expressing clones.
Ready-to-transfect synthetic gRNAs designed and validated to provide consistent high efficiency editing without compromising specificity.
“The LentiArray CRISPR libraries have allowed us to make significant inroads in our research on pediatric cancer, discovering a potentially novel strategy for the treatment of deadly brain tumors,” said Simone Treiger Sredni M.D., Ph.D., associate professor of pediatric neurosurgery at Northwestern University Feinberg School of Medicine. “Through the use of lenti-viral CRISPR-Cas9 particles, we identified an enzyme that can be inhibited by drugs and has been shown to prohibit tumor cell growth without affecting normal cells.”
For Research Use Only. Not for use in diagnostic procedures.
